文献速递重症综合管理与镇静镇痛

衰弱对年轻重症患者死亡的预测作用强于老年患者:一项前瞻性观察性研究

Frailty is a stronger predictor of death in younger intensive care patients than in older patients: a prospective observational study.
PubMed 文献 · Ann Intensive Care · 2022-12-31
一句话结论ICU前衰弱(CFS≥5)见于55%的64岁以下患者,仅中年(50-64岁)患者中衰弱独立关联180天死亡(校正HR 2.1)。

该前瞻性观察性研究在三级混合ICU纳入817例成人ICU患者,用CFS评估病前衰弱、SAPS3评估病情严重度,计算入ICU后180天死亡的风险比。衰弱(CFS≥5)占总体41%(n=333),并随年龄分层递增(19% vs 36% vs 56% vs 60%,P<0.05)。未校正时衰弱与各年龄组180天死亡风险升高相关(HR 5.7、8.0、4.1、2.4),但校正SAPS3、共病与治疗限制后仅50-64岁组仍显著(HR 2.1)。作者认为研究支持用衰弱评估识别死亡风险更高的年轻ICU患者。

要点

  • 817例成人ICU患者中衰弱(CFS≥5)占41%(n=333),18-49岁19%、50-64岁36%、65-79岁56%、≥80岁60%。
  • 未校正时衰弱与各年龄组180天死亡风险升高相关:18-49岁HR 5.7(95%CI 2.8-11.4)、50-64岁HR 8.0(4.0-16.2)、65-79岁HR 4.1(2.2-6.6)、≥80岁HR 2.4(1.1-5.0)。
  • 校正SAPS3、共病与治疗限制后,仅50-64岁组衰弱与180天死亡仍独立相关,HR 2.1(95%CI 1.1-3.1)。
  • 作者认为研究支持用衰弱评估识别死亡风险更高的年轻ICU患者。

适用人群与场景

  • 三级混合ICU的817例成人ICU患者,按预设年龄分为18-49岁(n=241)、50-64岁(n=188)、65-79岁(n=311)、80岁及以上(n=77)。

诊断标准与关键阈值

  • 病前衰弱用临床衰弱评分(CFS)评估,CFS≥5定义为衰弱。
  • 病情严重度用简化急性生理评分第三版(SAPS3)评估。

研究设计与关键结果

  • 前瞻性观察性研究,纳入817例成人ICU患者,收集病前CFS、SAPS3、治疗限制与结局,计算入ICU后180天死亡的风险比。
  • 衰弱(CFS≥5)占总体41%(n=333),各年龄组分别为18-49岁n=46(19%)、50-64岁n=67(36%)、65-79岁n=174(56%)、≥80岁n=46(60%),P<0.05。
  • 衰弱患者SAPS3更高、治疗限制更多、ICU死亡率更高。
  • 未校正时衰弱与各年龄组180天死亡风险升高相关:18-49岁HR 5.7(95%CI 2.8-11.4),P<0.05;50-64岁HR 8.0(4.0-16.2),P<0.05;65-79岁HR 4.1(2.2-6.6),P<0.05;≥80岁HR 2.4(1.1-5.0),P=0.02。
  • 校正SAPS3、共病与治疗限制后,仅50-64岁组衰弱与180天死亡仍显著相关,HR 2.1(95%CI 1.1-3.1),P<0.05。
  • 作者结论:病前衰弱在各年龄ICU患者中常见,64岁以下患者中占55%;衰弱仅在中中年患者中独立关联死亡,死亡风险增加两倍。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为研究支持用衰弱评估识别死亡风险更高的年轻ICU患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: While frailty is a known predictor of adverse outcomes in older patients, its effect in younger populations is unknown. This prospective observational study was conducted in a tertiary-level mixed ICU to assess the impact of frailty on long-term survival in intensive care patients of different ages.

METHODS: Data on premorbid frailty (Clinical Frailty Score; CFS), severity of illness (the Simplified Acute Physiology Score, third version; SAPS3), limitations of care and outcome were collected in 817 adult ICU patients. Hazard ratios (HR) for death within 180 days after ICU admission were calculated. Unadjusted and adjusted analyses were used to evaluate the association of frailty with outcome in different age groups.

RESULTS: Patients were classified into predefined age groups (18-49 years (n = 241), 50-64 (n = 188), 65-79 (n = 311) and 80 years or older (n = 77)). The proportion of frail (CFS ≥ 5) patients was 41% (n = 333) in the overall population and increased with each age strata (n = 46 (19%) vs. n = 67 (36%) vs. n = 174 (56%) vs. n = 46 (60%), P < 0.05). Frail patients had higher SAPS3, more treatment restrictions and higher ICU mortality. Frailty was associated with an increased risk of 180-day mortality in all age groups (HR 5.7 (95% CI 2.8-11.4), P < 0.05; 8.0 (4.0-16.2), P < 0.05; 4.1 (2.2-6.6), P < 0.05; 2.4 (1.1-5.0), P = 0.02). The effect remained significant after adjustment for SAPS3, comorbidity and limitations of treatment only in patients aged 50-64 (2.1 (1.1-3.1), P < 0.05).

CONCLUSIONS: Premorbid frailty is common in ICU patients of all ages and was found in 55% of patients aged under 64 years. Frailty was independently associated with mortality only among middle-aged patients, where the risk of death was increased twofold. Our study supports the use of frailty assessment in identifying younger ICU patients at a higher risk of death.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. De Geer L, Fredrikson M, Chew MS, et al. Frailty is a stronger predictor of death in younger intensive care patients than in older patients: a prospective observational study. Ann Intensive Care. 2022. PMID: 36586004. doi:10.1186/s13613-022-01098-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。